On Tuesday, Candel Therapeutics Inc (NASDAQ: CADL) was 7.68% up from the session before settling in for the closing price of $5.01. A 52-week range for CADL has been $3.79 – $14.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -20.00% over the past five years. When this article was written, the company’s average yearly earnings per share was at 40.03%. With a float of $36.07 million, this company’s outstanding shares have now reached $46.93 million.
Let’s look at the performance matrix of the company that is accounted for 38 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Candel Therapeutics Inc (CADL) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Candel Therapeutics Inc stocks. The insider ownership of Candel Therapeutics Inc is 26.80%, while institutional ownership is 41.12%. The most recent insider transaction that took place on Mar 18 ’25, was worth 396,995. In this transaction Chief Medical Officer of this company sold 45,316 shares at a rate of $8.76, taking the stock ownership to the 52,493 shares. Before that another transaction happened on Mar 18 ’25, when Company’s Chief Scientific Officer sold 32,146 for $8.76, making the entire transaction worth $281,673. This insider now owns 96,527 shares in total.
Candel Therapeutics Inc (CADL) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 40.03% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 28.77% during the next five years compared to -43.86% drop over the previous five years of trading.
Candel Therapeutics Inc (NASDAQ: CADL) Trading Performance Indicators
You can see what Candel Therapeutics Inc (CADL) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.75, a number that is poised to hit -0.27 in the next quarter and is forecasted to reach -1.29 in one year’s time.
Technical Analysis of Candel Therapeutics Inc (CADL)
Candel Therapeutics Inc (NASDAQ: CADL) saw its 5-day average volume 0.77 million, a negative change from its year-to-date volume of 1.14 million. As of the previous 9 days, the stock’s Stochastic %D was 66.19%. Additionally, its Average True Range was 0.44.
During the past 100 days, Candel Therapeutics Inc’s (CADL) raw stochastic average was set at 12.14%, which indicates a significant decrease from 84.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 70.53% in the past 14 days, which was lower than the 121.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.12, while its 200-day Moving Average is $6.50. Nevertheless, the first resistance level for the watch stands at $5.65 in the near term. At $5.90, the stock is likely to face the second major resistance level. The third major resistance level sits at $6.21. If the price goes on to break the first support level at $5.09, it is likely to go to the next support level at $4.78. The third support level lies at $4.53 if the price breaches the second support level.
Candel Therapeutics Inc (NASDAQ: CADL) Key Stats
There are 49,270K outstanding shares of the company, which has a market capitalization of 265.81 million. As of now, sales total 0 K while income totals -55,180 K. Its latest quarter income was 0 K while its last quarter net income were -14,070 K.
